explore -WSS

explore

author：comprehensive 2025-09-27 23:53:13 - browse：9

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Mark Cuban is blaming the wrong people for high drug costs

WSS

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Megan Rapinoe shares emotional post following US Women's World Cup exit

After Optum profits sink, UnitedHealth makes changes

Be careful with at

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Ebola: Gilead Sciences antiviral shows promise as new treatment

explore

explore

leisure time

Psychedelics group wrestles with new pharma identity

Male and female sex labels in research insufficient, scientists say

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: CAR

Continuity nursing helped my family in our darkest PICU moments

Why scientists need input from humanists on sensitive research

Novavax promises a turnaround & Lilly roils the obesity market

What to know about the judge who will handle the Trump case

How one medical school became remarkably diverse

How many hemophilia patients actually want gene therapy?

explore

Why depression after traumatic brain injury is distinct

Be careful with at

Amid AI frenzy, a top HHS official's quest to create safeguards

After Optum profits sink, UnitedHealth makes changes

John Green on his newest strategy for fighting tuberculosis

Megan Rapinoe shares emotional post following US Women's World Cup exit

Wikipedia

leisure time

entertainment

leisure time